The Riverside Company Invests In Australia’S Avance Clinical

Nov 21, 2021•over 3 years ago

Description

Global investment firm The Riverside Company has invested an undisclosed amount in Avance Clinical (Avance), an Australian contract research organisation (CRO) for international biotech firms, according to an announcement.

The Riverside Company Invests In Australia’S Avance Clinical

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information